Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
Clinical trial NCT00958971 · COMPLETED
Trial details
- NCT number
- NCT00958971
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.